Sinha Vikas

CIK 00013378455 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001337845

Recent Transactions

50 trades

Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2026-01-13$42.70/sh−16,755→ 583,245 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−94,112→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−72,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07+72,000→ 72,000 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−96,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−64,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−240,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−384→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−72,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Stock Units
2025-08-01−24,000→ 72,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01+24,000→ 98,440 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01$13.14/sh−4,328→ 94,112 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-05-20−160,000→ 384 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-20$0.50/sh+160,000→ 234,440 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-20$9.39/sh−160,000→ 74,440 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2025-05-02+110,067→ 110,067 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-04-29−4,952→ 195,048 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$8.92/sh−4,952→ 74,440 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$0.50/sh+4,952→ 79,392 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$8.92/sh−39,616→ 74,440 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$8.92/sh−120,384→ 74,440 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-04-29−120,384→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-04-29−15,048→ 80,952 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$0.50/sh+39,616→ 114,056 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$1.70/sh+15,048→ 89,488 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$1.70/sh+120,384→ 194,824 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$8.92/sh−15,048→ 74,440 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-04-29−39,616→ 160,384 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+100,000→ 100,000 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+500,000→ 600,000 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-25+96,000→ 96,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-02-21$10.08/sh−303→ 49,129 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.45/sh−116→ 49,445 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.94/sh−13→ 49,432 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-10$0.44/sh−979→ 1,139,915 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-19$0.55/sh−3,186→ 1,140,894 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-05$0.86/sh−5,136→ 1,144,080 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-22$0.77/sh−1,882→ 1,149,216 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-21$0.78/sh−1,546→ 1,151,098 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-03$0.81/sh−940→ 1,152,644 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-19$0.76/sh−3,159→ 1,153,584 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-05$0.73/sh−5,251→ 1,156,743 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-22$0.74/sh−1,858→ 1,161,994 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-19$0.75/sh−1,542→ 1,163,852 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-02$0.72/sh−939→ 1,165,394 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-17$0.75/sh−3,143→ 1,129,996 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-03$0.80/sh−4,957→ 1,133,139 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-22$0.75/sh−1,857→ 1,138,096 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-19$0.75/sh−1,521→ 1,139,953 total

Companies

Recent Filings

Address

301 BINNEY STREET

CAMBRIDGE, MA, 02142

View on SEC.gov